🔴 Recursion Pharmaceuticals Inc is trading 5% down today as it gives back part of its recent rally

Recursion Pharmaceuticals Inc is trading at $3.60 (-5.01%) as the stock retraces following a period of strength tied to its AI-driven drug discovery pipeline.

• The decline appears to be idiosyncratic rather than index-driven, as broader U.S. markets remain mixed with no clear macroeconomic catalyst for the move.
• No new company-specific announcements or regulatory filings were released to explain the June 02 price action.
• The move suggests a cooling of recent optimism or potential profit-taking, though a delayed analyst note or update could still emerge.